Acta biochimica et biophysica Sinica最新文献

筛选
英文 中文
Exploring the mechanism of Panax notoginseng saponin in inhibiting the inflammatory response of microglia in cerebral ischemia based on network pharmacology. 基于网络药理学探讨三七皂苷抑制脑缺血小胶质细胞炎症反应的机制
IF 3.3 2区 生物学
Acta biochimica et biophysica Sinica Pub Date : 2024-07-05 DOI: 10.3724/abbs.2024114
Zhaoda Duan, Wenji Jia, Jianxiang Wang, Dongyao Xu, Yujia Yang, Zhi Qi, Li Yang, Chunyun Wu
{"title":"Exploring the mechanism of <i>Panax notoginseng</i> saponin in inhibiting the inflammatory response of microglia in cerebral ischemia based on network pharmacology.","authors":"Zhaoda Duan, Wenji Jia, Jianxiang Wang, Dongyao Xu, Yujia Yang, Zhi Qi, Li Yang, Chunyun Wu","doi":"10.3724/abbs.2024114","DOIUrl":"10.3724/abbs.2024114","url":null,"abstract":"","PeriodicalId":6978,"journal":{"name":"Acta biochimica et biophysica Sinica","volume":null,"pages":null},"PeriodicalIF":3.3,"publicationDate":"2024-07-05","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11532199/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141553941","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"生物学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
CCL2 promotes EGFR-TKIs resistance in non-small cell lung cancer via the AKT-EMT pathway. CCL2 通过 AKT-EMT 通路促进非小细胞肺癌对表皮生长因子受体-TKIs 的耐药性。
IF 3.3 2区 生物学
Acta biochimica et biophysica Sinica Pub Date : 2024-07-03 DOI: 10.3724/abbs.2024106
Yunlian Diao, Shibo Huang, Fangpeng Liu, Shu Liao, Chenxi Guan, Xiaojian Xiong, Ping Zhang, Junyao Li, Wei Zhang, Ying Ying
{"title":"CCL2 promotes EGFR-TKIs resistance in non-small cell lung cancer via the AKT-EMT pathway.","authors":"Yunlian Diao, Shibo Huang, Fangpeng Liu, Shu Liao, Chenxi Guan, Xiaojian Xiong, Ping Zhang, Junyao Li, Wei Zhang, Ying Ying","doi":"10.3724/abbs.2024106","DOIUrl":"10.3724/abbs.2024106","url":null,"abstract":"<p><p>Acquired resistance to EGFR tyrosine kinase inhibitors (EGFR-TKIs) represents a primary cause of treatment failure in non-small cell lung cancer (NSCLC) patients. Chemokine (C-C motif) ligand 2 (CCL2) is recently found to play a pivotal role in determining anti-cancer treatment response. However, the role and mechanism of CCL2 in the development of EGFR-TKIs resistance have not been fully elucidated. In the present study, we focus on the function of CCL2 in the development of acquired resistance to EGFR-TKIs in NSCLC cells. Our results show that CCL2 is aberrantly upregulated in EGFR-TKIs-resistant NSCLC cells and that CCL2 overexpression significantly diminishes sensitivity to EGFR-TKIs. Conversely, CCL2 suppression by CCL2 synthesis inhibitor, bindarit, or <i>CCL2</i> knockdown can reverse this resistance. CCL2 upregulation can also lead to enhanced migration and increased expressions of epithelial-mesenchymal transition (EMT) markers in EGFR-TKI-resistant NSCLC cells, which could also be rescued by <i>CCL2</i> knockdown or inhibition. Furthermore, our findings suggest that CCL2-dependent EGFR-TKIs resistance involves the AKT-EMT signaling pathway; inhibition of this pathway effectively attenuates CCL2-induced cell migration and EMT marker expression. In summary, CCL2 promotes the development of acquired EGFR-TKIs resistance and EMT while activating AKT signaling in NSCLC. These insights suggest a promising avenue for the development of CCL2-targeted therapies that prevent EGFR-TKIs resistance in NSCLC.</p>","PeriodicalId":6978,"journal":{"name":"Acta biochimica et biophysica Sinica","volume":null,"pages":null},"PeriodicalIF":3.3,"publicationDate":"2024-07-03","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11532253/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141496817","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"生物学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
O-GlcNAcylation determines the function of the key O-GalNAc glycosyltransferase C1GalT1 in bladder cancer O-GlcNAcylation决定了膀胱癌中关键的O-GalNAc糖基转移酶C1GalT1的功能
IF 3.3 2区 生物学
Acta biochimica et biophysica Sinica Pub Date : 2024-07-01 DOI: 10.3724/abbs.2024129
Yazhuo Jiang, Jinpeng Wu, Feng Guan, Liang Liang, Wang Yili
{"title":"O-GlcNAcylation determines the function of the key O-GalNAc glycosyltransferase C1GalT1 in bladder cancer","authors":"Yazhuo Jiang, Jinpeng Wu, Feng Guan, Liang Liang, Wang Yili","doi":"10.3724/abbs.2024129","DOIUrl":"https://doi.org/10.3724/abbs.2024129","url":null,"abstract":"","PeriodicalId":6978,"journal":{"name":"Acta biochimica et biophysica Sinica","volume":null,"pages":null},"PeriodicalIF":3.3,"publicationDate":"2024-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141845291","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"生物学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
ADATs: roles in tRNA editing and relevance to disease ADAT:在 tRNA 编辑中的作用以及与疾病的关系
IF 3.3 2区 生物学
Acta biochimica et biophysica Sinica Pub Date : 2024-07-01 DOI: 10.3724/abbs.2024125
Xueling Mao, Gilbert Eriani, Xiao-Long Zhou
{"title":"ADATs: roles in tRNA editing and relevance to disease","authors":"Xueling Mao, Gilbert Eriani, Xiao-Long Zhou","doi":"10.3724/abbs.2024125","DOIUrl":"https://doi.org/10.3724/abbs.2024125","url":null,"abstract":"","PeriodicalId":6978,"journal":{"name":"Acta biochimica et biophysica Sinica","volume":null,"pages":null},"PeriodicalIF":3.3,"publicationDate":"2024-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141691427","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"生物学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
EEPD1 attenuates radiation-induced cardiac hypertrophy and apoptosis by degrading FOXO3A in cardiomyocytes EEPD1 通过降解心肌细胞中的 FOXO3A 减轻辐射诱导的心脏肥大和凋亡
IF 3.3 2区 生物学
Acta biochimica et biophysica Sinica Pub Date : 2024-07-01 DOI: 10.3724/abbs.2024130
Kaiwen Yu, Xi Su, Tongfang Zhou, Xuwei Cai, Min Zhang
{"title":"<italic>EEPD1</italic> attenuates radiation-induced cardiac hypertrophy and apoptosis by degrading <italic>FOXO3A</italic> in cardiomyocytes","authors":"Kaiwen Yu, Xi Su, Tongfang Zhou, Xuwei Cai, Min Zhang","doi":"10.3724/abbs.2024130","DOIUrl":"https://doi.org/10.3724/abbs.2024130","url":null,"abstract":"","PeriodicalId":6978,"journal":{"name":"Acta biochimica et biophysica Sinica","volume":null,"pages":null},"PeriodicalIF":3.3,"publicationDate":"2024-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141845775","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"生物学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Inherited glycosylphosphatidylinositol deficiency: a review from molecular and clinical perspectives 遗传性糖基磷脂酰肌醇缺乏症:从分子和临床角度综述
IF 3.3 2区 生物学
Acta biochimica et biophysica Sinica Pub Date : 2024-07-01 DOI: 10.3724/abbs.2024128
Shan Li, Qi Tang, Yuwu Jiang, Xing Chen
{"title":"Inherited glycosylphosphatidylinositol deficiency: a review from molecular and clinical perspectives","authors":"Shan Li, Qi Tang, Yuwu Jiang, Xing Chen","doi":"10.3724/abbs.2024128","DOIUrl":"https://doi.org/10.3724/abbs.2024128","url":null,"abstract":"","PeriodicalId":6978,"journal":{"name":"Acta biochimica et biophysica Sinica","volume":null,"pages":null},"PeriodicalIF":3.3,"publicationDate":"2024-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141848474","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"生物学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Intestinal microbiota dysbiosis contributed to the development of subchronic liver damage in arsenic-exposed mice 肠道微生物群失调导致砷暴露小鼠亚慢性肝损伤的发生
IF 3.3 2区 生物学
Acta biochimica et biophysica Sinica Pub Date : 2024-07-01 DOI: 10.3724/abbs.2024131
Ling Dong, Peng Luo, Aihua Zhang*
{"title":"Intestinal microbiota dysbiosis contributed to the development of subchronic liver damage in arsenic-exposed mice","authors":"Ling Dong, Peng Luo, Aihua Zhang*","doi":"10.3724/abbs.2024131","DOIUrl":"https://doi.org/10.3724/abbs.2024131","url":null,"abstract":"","PeriodicalId":6978,"journal":{"name":"Acta biochimica et biophysica Sinica","volume":null,"pages":null},"PeriodicalIF":3.3,"publicationDate":"2024-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141847571","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"生物学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
SPATS2L is a positive feedback regulator of the type I interferon signaling pathway and plays a vital role in lupus SPATS2L 是 I 型干扰素信号通路的正反馈调节器,在狼疮中发挥着重要作用
IF 3.3 2区 生物学
Acta biochimica et biophysica Sinica Pub Date : 2024-07-01 DOI: 10.3724/abbs.2024132
Mengke Chen, Yutong Zhang, Weiwen Shi, Xuejiao Song, Yue Yang, Guojun Hou, Huihua Ding, Sheng Chen, Wanling Yang, Nan Shen, Yong Cui, Xianbo Zuo, Yuanjia Tang
{"title":"SPATS2L is a positive feedback regulator of the type I interferon signaling pathway and plays a vital role in lupus","authors":"Mengke Chen, Yutong Zhang, Weiwen Shi, Xuejiao Song, Yue Yang, Guojun Hou, Huihua Ding, Sheng Chen, Wanling Yang, Nan Shen, Yong Cui, Xianbo Zuo, Yuanjia Tang","doi":"10.3724/abbs.2024132","DOIUrl":"https://doi.org/10.3724/abbs.2024132","url":null,"abstract":"","PeriodicalId":6978,"journal":{"name":"Acta biochimica et biophysica Sinica","volume":null,"pages":null},"PeriodicalIF":3.3,"publicationDate":"2024-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141847055","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"生物学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Mass spectrometry-based structure-specific N-glycoproteomics and biomedical applications 基于质谱的特异结构 N-糖蛋白组学与生物医学应用
IF 3.3 2区 生物学
Acta biochimica et biophysica Sinica Pub Date : 2024-07-01 DOI: 10.3724/abbs.2024133
Ming Bi, Zhixin Tian
{"title":"Mass spectrometry-based structure-specific <italic>N-</italic>glycoproteomics and biomedical applications","authors":"Ming Bi, Zhixin Tian","doi":"10.3724/abbs.2024133","DOIUrl":"https://doi.org/10.3724/abbs.2024133","url":null,"abstract":"","PeriodicalId":6978,"journal":{"name":"Acta biochimica et biophysica Sinica","volume":null,"pages":null},"PeriodicalIF":3.3,"publicationDate":"2024-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141842775","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"生物学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Glyco-signatures in patients with advanced lung cancer during anti-PD-1/PD-L1 immunotherapy. 晚期肺癌患者在接受抗 PD-1/PD-L1 免疫疗法期间的糖代谢特征。
IF 3.3 2区 生物学
Acta biochimica et biophysica Sinica Pub Date : 2024-06-28 DOI: 10.3724/abbs.2024110
Xinyi Cao, Zhihuang Hu, Xiangying Sheng, Zhenyu Sun, Lijun Yang, Hong Shu, Xiaojing Liu, Guoquan Yan, Lei Zhang, Chao Liu, Ying Zhang, Huijie Wang, Haojie Lu
{"title":"Glyco-signatures in patients with advanced lung cancer during anti-PD-1/PD-L1 immunotherapy.","authors":"Xinyi Cao, Zhihuang Hu, Xiangying Sheng, Zhenyu Sun, Lijun Yang, Hong Shu, Xiaojing Liu, Guoquan Yan, Lei Zhang, Chao Liu, Ying Zhang, Huijie Wang, Haojie Lu","doi":"10.3724/abbs.2024110","DOIUrl":"10.3724/abbs.2024110","url":null,"abstract":"<p><p>Immune checkpoint inhibitors (ICIs) targeting programmed cell death 1/programmed cell death ligand-1 (PD-1/PD-L1) have significantly prolonged the survival of advanced/metastatic patients with lung cancer. However, only a small proportion of patients can benefit from ICIs, and clinical management of the treatment process remains challenging. Glycosylation has added a new dimension to advance our understanding of tumor immunity and immunotherapy. To systematically characterize anti-PD-1/PD-L1 immunotherapy-related changes in serum glycoproteins, a series of serum samples from 12 patients with metastatic lung squamous cell carcinoma (SCC) and lung adenocarcinoma (ADC), collected before and during ICIs treatment, are firstly analyzed with mass-spectrometry-based label-free quantification method. Second, a stratification analysis is performed among anti-PD-1/PD-L1 responders and non-responders, with serum levels of glycopeptides correlated with treatment response. In addition, in an independent validation cohort, a large-scale site-specific profiling strategy based on chemical labeling is employed to confirm the unusual characteristics of IgG N-glycosylation associated with anti-PD-1/PD-L1 treatment. Unbiased label-free quantitative glycoproteomics reveals serum levels' alterations related to anti-PD-1/PD-L1 treatment in 27 out of 337 quantified glycopeptides. The intact glycopeptide EEQFN <sup>177</sup>STYR (H3N4) corresponding to IgG4 is significantly increased during anti-PD-1/PD-L1 treatment (FC=2.65, <i>P</i>=0.0083) and has the highest increase in anti-PD-1/PD-L1 responders (FC=5.84, <i>P</i>=0.0190). Quantitative glycoproteomics based on protein purification and chemical labeling confirms this observation. Furthermore, obvious associations between the two intact glycopeptides (EEQFN <sup>177</sup>STYR (H3N4) of IgG4, EEQYN <sup>227</sup>STFR (H3N4F1) of IgG3) and response to treatment are observed, which may play a guiding role in cancer immunotherapy. Our findings could benefit future clinical disease management.</p>","PeriodicalId":6978,"journal":{"name":"Acta biochimica et biophysica Sinica","volume":null,"pages":null},"PeriodicalIF":3.3,"publicationDate":"2024-06-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11464919/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141475719","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"生物学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
相关产品
×
本文献相关产品
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信